Investigating Neural Biomarkers for Gait in Parkinson's Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSwiss Federal Institute of Technology
About this trial
This observational study's main goal is to learn more about the neural mechanisms during movement in Parkinson's disease. Furthermore, it aims to inspire personalised treatment options.
Participants will undergo a protocol that involves walking and gait-related motor tasks, such as seated stepping. During the protocol, brain activity will be recorded.
Eligibility criteria
Qualifiers
must have given informed consent as documented by signature
agree to comply with the study procedures
no neurological, orthopedic, or rheumatologic disease history
no identified sensory impairment.
Disqualifiers
Relevant cognitive impairment, with a score on Montréal Cognitive Assessment (MoCA) < 20
History of physical or neurological condition that interferes with study procedures
Social and/or personal circumstances interfering with the ability to come to the session
Trial design
Treatments tested in this trial
- Neural Activity Recording
- Movement Parameter Recording
- Neuromodulation
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Swiss Federal Institute of Technology
Lead sponsor
cereneo center for Neurology and Rehabilitation
Collaborator
University of Zurich
Collaborator
Source ClinicalTrials.gov